AbCellera Biologics Inc.
ABCL
Rank in Stocks
#4140
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the... AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
Share Price
$11.99
Last synced: 2026-10-19
Market Cap
$3.88B
Change (1 day)
1.57%
Change (1 year)
104.52%
Country
CA
Trade AbCellera Biologics Inc. (ABCL)
Category
Healthcare
Stock split history for AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Inc. stock (symbol: ABCL) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One ABCL share bought prior to Oct 20, 2026 would equal to 0 ABCL shares today.
The most recent stock split occurred on Oct 20, 2026.
One ABCL share bought prior to Oct 20, 2026 would equal to 0 ABCL shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
